HY-P9934-1mg
|
MedChemexpress LLC
|
Abciximab [CAS 143653-53-6]
|
|
Neuroscience-Neuromodulation
|
|
HY-P9934-10mg
|
MedChemexpress LLC
|
Abciximab [CAS 143653-53-6]
|
|
Neuroscience-Neuromodulation
|
|
HY-P9934-5mg
|
MedChemexpress LLC
|
Abciximab [CAS 143653-53-6]
|
|
Neuroscience-Neuromodulation
|
|
HY-P9928A-2mg
|
MedChemexpress LLC
|
Alirocumab (anti-PCSK9) [CAS 1245916-14-6]
|
|
Neuroscience-Neuromodulation
|
|
HY-P9928A-5mg
|
MedChemexpress LLC
|
Alirocumab (anti-PCSK9) [CAS 1245916-14-6]
|
|
Neuroscience-Neuromodulation
|
|
HY-P9914-1mg
|
MedChemexpress LLC
|
Eculizumab [CAS 219685-50-4]
|
|
Neuroscience-Neuromodulation
|
|
HY-P9914-5mg
|
MedChemexpress LLC
|
Eculizumab [CAS 219685-50-4]
|
|
Neuroscience-Neuromodulation
|
|
HY-P99017-1mg
|
MedChemexpress LLC
|
Eptinezumab [CAS 1644539-04-7]
|
|
Neuroscience-Neuromodulation
|
|
HY-P99017-10mg
|
MedChemexpress LLC
|
Eptinezumab [CAS 1644539-04-7]
|
|
Neuroscience-Neuromodulation
|
|
HY-P99017-5mg
|
MedChemexpress LLC
|
Eptinezumab [CAS 1644539-04-7]
|
|
Neuroscience-Neuromodulation
|
|
HY-P9938-1mg
|
MedChemexpress LLC
|
Erenumab [CAS 1582205-90-0]
|
|
Neuroscience-Neuromodulation
|
|
HY-P9938-10mg
|
MedChemexpress LLC
|
Erenumab [CAS 1582205-90-0]
|
|
Neuroscience-Neuromodulation
|
|
HY-P9938-5mg
|
MedChemexpress LLC
|
Erenumab [CAS 1582205-90-0]
|
|
Neuroscience-Neuromodulation
|
|
HY-P99631-1mg
|
MedChemexpress LLC
|
Garadacimab [CAS 2162134-62-3]
|
|
Neuroscience-Neuromodulation
|
|
HY-P99631-10mg
|
MedChemexpress LLC
|
Garadacimab [CAS 2162134-62-3]
|
|
Neuroscience-Neuromodulation
|
|
HY-P99631-5mg
|
MedChemexpress LLC
|
Garadacimab [CAS 2162134-62-3]
|
|
Neuroscience-Neuromodulation
|
|
HY-P99263-1mg
|
MedChemexpress LLC
|
Inclacumab [CAS 1256258-86-2]
|
|
Neuroscience-Neuromodulation
|
|
HY-P99263-10mg
|
MedChemexpress LLC
|
Inclacumab [CAS 1256258-86-2]
|
|
Neuroscience-Neuromodulation
|
|
HY-P99263-5mg
|
MedChemexpress LLC
|
Inclacumab [CAS 1256258-86-2]
|
|
Neuroscience-Neuromodulation
|
|